Akèy › Maladi fwa › Arizona › Chandler
Etid klinik pou Maladi fwa nan Chandler, AZ
4 etid pou Maladi fwa ap chèche patisipan nan sit nan ak bò kote Chandler (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Ap rekriteFaz 2
- Arizona Liver Health, Chandler
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Ap rekriteFaz 3
- 89bio Clinical Study Site, Chandler
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Ap rekriteFaz 3
- 89bio Clinical Study Site, Chandler
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
Ap rekriteFaz 1
- Arizona Clinical Trials - the Institute For Liver Health, Chandler
Etid Maladi fwa nan lòt vil
- Houston, TX10 etid
- Chicago, IL9 etid
- Washington, DC8 etid
- Los Angeles, CA7 etid
- Atlanta, GA7 etid
- Richmond, VA6 etid
- New York City, NY6 etid
- San Antonio, TX6 etid
- Philadelphia, PA6 etid
- Dallas, TX5 etid
- Durham, NC5 etid
- Ann Arbor, MI5 etid
Lòt etid nan Chandler
- Maladi fwa steatotik10 etid
- Kansè Poumon ki pa ti selil5 etid
- Kansè nan tete5 etid
- Kansè kolorektal5 etid
- Maladi Dijestif5 etid
- Obèsite5 etid
- Kansè Metastatik4 etid
- Dyabèt Tip 24 etid
- Sipwa4 etid
- Siròz3 etid
- Maladi Alzheimer3 etid
- Maladi kadyovaskilè3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.